BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

Overview of attention for article published in OncoTargets and therapy, September 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 82 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Heterocyclic compounds as BET inhibitors

Grant US-11584756-B2

United States of America

Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors

Grant US-11192900-B2

United States of America